These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37234934)

  • 21. Strain Wars: Competitive interactions between SARS-CoV-2 strains are explained by Gibbs energy of antigen-receptor binding.
    Popovic M; Popovic M
    Microb Risk Anal; 2022 Aug; 21():100202. PubMed ID: 35155724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Variants Detection Using TaqMan SARS-CoV-2 Mutation Panel Molecular Genotyping Assays.
    Neopane P; Nypaver J; Shrestha R; Beqaj SS
    Infect Drug Resist; 2021; 14():4471-4479. PubMed ID: 34737587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of the mechanisms of SARS-CoV-2 evolution and transmission.
    Chen J; Wang R; Wei GW
    ArXiv; 2021 Sep; ():. PubMed ID: 34545334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
    Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strain wars 5: Gibbs energies of binding of BA.1 through BA.4 variants of SARS-CoV-2.
    Popovic M
    Microb Risk Anal; 2022 Dec; 22():100231. PubMed ID: 36034590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients.
    Carreño JM; Alshammary H; Singh G; Raskin A; Amanat F; Amoako A; Gonzalez-Reiche AS; van de Guchte A; Study Group P; Srivastava K; Sordillo EM; Sather DN; van Bakel H; Krammer F; Simon V
    EBioMedicine; 2021 Nov; 73():103626. PubMed ID: 34688034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron.
    Teng IT; Nazzari AF; Choe M; Liu T; Oliveira de Souza M; Petrova Y; Tsybovsky Y; Wang S; Zhang B; Artamonov M; Madan B; Huang A; Lopez Acevedo SN; Pan X; Ruckwardt TJ; DeKosky BJ; Mascola JR; Misasi J; Sullivan NJ; Zhou T; Kwong PD
    PLoS One; 2022; 17(5):e0268767. PubMed ID: 35609088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution.
    Nunes DR; Braconi CT; Ludwig-Begall LF; Arns CW; Durães-Carvalho R
    PLoS One; 2022; 17(5):e0268389. PubMed ID: 35609034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves.
    Alcantara LCJ; Nogueira E; Shuab G; Tosta S; Fristch H; Pimentel V; Souza-Neto JA; Coutinho LL; Fukumasu H; Sampaio SC; Elias MC; Kashima S; Slavov SN; Ciccozzi M; Cella E; Lourenco J; Fonseca V; Giovanetti M
    Virus Res; 2022 Jul; 315():198785. PubMed ID: 35461905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants.
    Hu YF; Hu JC; Gong HR; Danchin A; Sun R; Chu H; Hung IF; Yuen KY; To KK; Zhang BZ; Yau T; Huang JD
    Front Immunol; 2022; 13():861050. PubMed ID: 35401572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strain wars 3: Differences in infectivity and pathogenicity between Delta and Omicron strains of SARS-CoV-2 can be explained by thermodynamic and kinetic parameters of binding and growth.
    Popovic M
    Microb Risk Anal; 2022 Dec; 22():100217. PubMed ID: 35434234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization.
    Zhang L; Cui Z; Li Q; Wang B; Yu Y; Wu J; Nie J; Ding R; Wang H; Zhang Y; Liu S; Chen Z; He Y; Su X; Xu W; Huang W; Wang Y
    Commun Biol; 2021 Oct; 4(1):1196. PubMed ID: 34645933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the Origins of Omicron's Unique Spike Gene Insertion.
    Venkatakrishnan AJ; Anand P; Lenehan PJ; Suratekar R; Raghunathan B; Niesen MJM; Soundararajan V
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
    Darvishi M; Rahimi F; Talebi Bezmin Abadi A
    Gene Rep; 2021 Dec; 25():101378. PubMed ID: 34632160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A thermodynamic insight into viral infections: do viruses in a lytic cycle hijack cell metabolism due to their low Gibbs energy?
    Popovic M; Minceva M
    Heliyon; 2020 May; 6(5):e03933. PubMed ID: 32420495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: Genetic relations and vaccine strain match.
    Perbolianachis P; Ferla D; Arce R; Ferreiro I; Costábile A; Paz M; Simón D; Moreno P; Cristina J
    Virus Res; 2022 Apr; 311():198688. PubMed ID: 35074431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2.
    Celik I; Khan A; Dwivany FM; Fatimawali ; Wei DQ; Tallei TE
    Mol Divers; 2022 Dec; 26(6):3309-3324. PubMed ID: 35138508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy.
    Lai A; Bergna A; Della Ventura C; Menzo S; Bruzzone B; Sagradi F; Ceccherini-Silberstein F; Weisz A; Clementi N; Brindicci G; Vicenti I; Sasset L; Caucci S; Corvaro B; Ippoliti S; Acciarri C; De Pace V; Lanfranchi L; Bellocchi MC; Giurato G; Ferrarese R; Lagioia A; Francisci D; Colombo ML; Lazzarin S; Ogliastro M; Cappelletti MR; Iannetta M; Rizzo F; Torti C; Fumi M; d'Avenia M; Brusa S; Greco F; Menchise A; Letizia V; Vaccaro E; Santoro CR; Fraccalvieri C; Testa S; Carioti L; Rocco T; Saracino A; Cattelan A; Clementi M; Sarmati L; Riva A; Galli M; Antinori S; Zehender G; Sars-CoV-Italian Research Enterprise-Scire Collaborative Group
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron.
    Teng IT; Nazzari AF; Choe M; Liu T; Oliveira de Souza M; Petrova Y; Tsybovsky Y; Wang S; Zhang B; Artamonov M; Madan B; Huang A; Lopez Acevedo SN; Pan X; Ruckwardt TJ; DeKosky BJ; Mascola JR; Misasi J; Sullivan NJ; Zhou T; Kwong PD
    bioRxiv; 2021 Dec; ():. PubMed ID: 35018379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.